Paradigm Biopharmaceutical Ltd's PPS heart failure treatment generates promising data from pre-clinical animal model trial
![Urokinase Market Increasing prevalence of pulmonary embolism is driving growth of Market 2028 | Jiangsu Aidea Pharmaceutical Co Ltd, Jiangxi Haoran Bio-Pharma Co. Ltd, Cadila Healthcare Limited, Wilex AG. | Medgadget Urokinase Market Increasing prevalence of pulmonary embolism is driving growth of Market 2028 | Jiangsu Aidea Pharmaceutical Co Ltd, Jiangxi Haoran Bio-Pharma Co. Ltd, Cadila Healthcare Limited, Wilex AG. | Medgadget](https://www.medgadget.com/wp-content/uploads/2022/02/urokinase-market-370x223.jpg)
Urokinase Market Increasing prevalence of pulmonary embolism is driving growth of Market 2028 | Jiangsu Aidea Pharmaceutical Co Ltd, Jiangxi Haoran Bio-Pharma Co. Ltd, Cadila Healthcare Limited, Wilex AG. | Medgadget
![Biohaven Announces Preliminary 2Q2021 Net Product Revenue For NURTEC ODT, The First And Only Migraine Medication For Both Acute And Preventive Treatment Biohaven Announces Preliminary 2Q2021 Net Product Revenue For NURTEC ODT, The First And Only Migraine Medication For Both Acute And Preventive Treatment](https://mma.prnewswire.com/media/413973/Biohaven_Pharmaceutical_Holding_Company_Ltd_Logo.jpg?p=facebook)